UFPT UFP Technologies, Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
21.31
PEG
1.35
P/B
4.03
P/S
2.91
EV/EBITDA
16.41
DCF Value
$252.98
FCF Yield
3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
28.4%
Operating Margin
15.2%
Net Margin
11.3%
ROE
16.6%
ROA
10.2%
ROIC
12.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $154.2M | $17.5M | $— |
| Q4 null | $148.9M | $17.6M | $— |
| FY null | $602.8M | $68.3M | $— |
| Q3 null | $154.6M | $16.4M | $— |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$298.00
Target (Median)
$298.00
Target Range
$252.00 - $344.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.08
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.